DEAOU Biotechnology Ltd. is a national certified high-tech enterprise, founded by a scientist from nation global experts recruitment program in 2008, acting as the leading industrializing company in national 12th, 13th 5-year Infectious Diseases Science Major Project.       DEAOU has successfully developed over 120 types of testing reagent products and 10 supporting detection instruments based on patented technologies, with applications ranging from infectious diseases diagnostics to food safety testing. Deaou’s products have been deployed to over 600 CDC laboratories at different levels, over 200 infectious diseases designated hospitals, other governmental and third party detection labs.        In terms of production capacity, Deaou has multiple detection reagent which guarantee weekly capacity of 1 million test kits. With the implementation of extensive quality management system (QMS), safe operations and up to date compliance with CFDA standards are well ensured.      In responds to the outbreak of novel coronavirus, Deaou has successfully developed a high-performance testing solution for the covid-19 virus, which includes virus sampling tools, nucleic acid purification reagents and RT-PCR detection kits.
Obtained nearly           patents with independent intellectual property rights
completed more than              types of detection reagents
developed         kinds of detection instruments
Guangdong ICP No. 16024184 Guangzhou Deaou Bio-technology Co., Ltd.
Detecting Instruments
Quality Management System